Cite
MLA Citation
Shaji Kumar et al.. “Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma.” British journal of haematology, vol. 178, 2017, pp. 571–582. http://access.bl.uk/ark:/81055/vdc_100047732304.0x000058